Literature DB >> 26367228

Sirolimus-related anal ulceration in a female patient after allogeneic stem cell transplantation.

L Haïk1, M Beylot-Barry2,3, S Vigouroux1, R Tabrizi1, N Milpied1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26367228     DOI： 10.1038/bmt.2015.198

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  13 in total

Review 1.  Rapamycin in transplantation: a review of the evidence.

Authors:  R N Saunders; M S Metcalfe; M L Nicholson
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

2.  Mucocutaneous disorders in renal transplant recipients receiving sirolimus-based immunosuppressive therapy: a prospective, case-control study.

Authors:  Deren Özcan; Deniz Seçkin; Simin Ada; Mehmet Haberal
Journal:  Clin Transplant       Date:  2013-08-31       Impact factor: 2.863

3.  Sirolimus-related toxicity in stem cell transplantation.

Authors:  Alessandro Busca; Franco Locatelli; Donatella Moscato; Michele Falda
Journal:  Biol Blood Marrow Transplant       Date:  2005-08       Impact factor: 5.742

4.  Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT.

Authors:  Corey Cutler; Brent Logan; Ryotaro Nakamura; Laura Johnston; Sung Choi; David Porter; William J Hogan; Marcelo Pasquini; Margaret L MacMillan; Jack W Hsu; Edmund K Waller; Stephan Grupp; Philip McCarthy; Juan Wu; Zhen-Huan Hu; Shelly L Carter; Mary M Horowitz; Joseph H Antin
Journal:  Blood       Date:  2014-06-30       Impact factor: 22.113

Review 5.  Use of sirolimus in solid organ transplantation.

Authors:  Joshua J Augustine; Kenneth A Bodziak; Donald E Hricik
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease.

Authors:  Laura J Johnston; Janice Brown; Judith A Shizuru; Keith E Stockerl-Goldstein; Monic J Stuart; Karl G Blume; Robert S Negrin; Nelson J Chao
Journal:  Biol Blood Marrow Transplant       Date:  2005-01       Impact factor: 5.742

Review 7.  Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantation.

Authors:  C Cutler; J H Antin
Journal:  Bone Marrow Transplant       Date:  2004-09       Impact factor: 5.483

8.  A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications.

Authors:  Marzia Montalbano; Guy W Neff; Noriyo Yamashiki; Douglas Meyer; Marina Bettiol; Gabriella Slapak-Green; Phillip Ruiz; Emory Manten; Kamran Safdar; Christopher O'Brien; Andreas G Tzakis
Journal:  Transplantation       Date:  2004-07-27       Impact factor: 4.939

9.  [Oral ulcers in kidney allograft recipients treated with sirolimus].

Authors:  J-C Fricain; K Cellerié; V Sibaud; S Catros; A Taïeb; P Merville
Journal:  Ann Dermatol Venereol       Date:  2008-09-17       Impact factor: 0.777

10.  Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency.

Authors:  G W Neff; M Montalbano; G Slapak-Green; D Meyer; T Berney; K Safdar; E R Schiff; A G Tzakis
Journal:  Transplant Proc       Date:  2003-12       Impact factor: 1.066
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.